Zoetis (ZTS) Share-based Compensation (2012 - 2026)
Zoetis (ZTS) reported Share-based Compensation of $25.0 million for Q1 2026, up 47.06% year-over-year from $17.0 million in Q1 2025, and up 13.64% quarter-over-quarter from $22.0 million in Q4 2025.
Zoetis (ZTS) Share-based Compensation (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Share-based Compensation data on file, last reported at $25.0 million in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $25.0 million, up 47.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.0 million (up 24.66% YoY), and the FY2025 annual result was $83.0 million, up 12.16% from the prior year.
- Share-based Compensation advanced to $25.0 million in Q1 2026 per ZTS's latest filing, from $22.0 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $25.0 million in Q1 2026 and troughed at $9.0 million in Q1 2023.
- A 5-year average of $17.9 million and a median of $17.0 million in 2023 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation tumbled 43.75% in 2023, then jumped 100.0% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $16.0 million in 2022, then gained by 6.25% to $17.0 million in 2023, then climbed by 11.76% to $19.0 million in 2024, then rose by 15.79% to $22.0 million in 2025, then gained by 13.64% to $25.0 million in 2026.
- Business Quant data shows ZTS's Share-based Compensation at $25.0 million in Q1 2026, $22.0 million in Q4 2025, and $22.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.00 Mn |
| Mar 31, 2026 | 25.00 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 22.00 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | 19.00 Mn |
| Dec 31, 2024 | 19.00 Mn |
| Sep 30, 2024 | 18.00 Mn |
| Sep 30, 2024 | 18.00 Mn |
| Jun 30, 2024 | 19.00 Mn |
| Jun 30, 2024 | 19.00 Mn |
| Mar 31, 2024 | 18.00 Mn |
| Mar 31, 2024 | 18.00 Mn |
| Dec 31, 2023 | 17.00 Mn |
| Dec 31, 2023 | 17.00 Mn |